These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9845499)

  • 1. Zidovudine safety and tolerance among uninfected healthcare workers: a brief update.
    Beekmann SE; Fahrner R; Henderson DK; Gerberding JL
    Am J Med; 1997 May; 102(5B):63-4. PubMed ID: 9845499
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of antiretroviral agents.
    Struble KA; Pratt RD; Gitterman SR
    Am J Med; 1997 May; 102(5B):65-7; discussion 68-9. PubMed ID: 9845500
    [No Abstract]   [Full Text] [Related]  

  • 3. Zidovudine toxicity in uninfected healthcare workers. Italian Registry of Antiretroviral Prophylaxis.
    Ippolito G; Puro V
    Am J Med; 1997 May; 102(5B):58-62. PubMed ID: 9845498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
    D'Amico R; Pinto LA; Meyer P; Landay AL; Harris AA; Clerici M; Berzofsky JA; Shearer GM; Kessler HA
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):428-30. PubMed ID: 10395147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The management of the occupational exposures of health workers to HIV].
    Escribano Hernández A
    Aten Primaria; 1997 Jun; 20(1):54-6. PubMed ID: 9303664
    [No Abstract]   [Full Text] [Related]  

  • 6. Report updates recommendations for health workers exposed to HIV.
    Am J Health Syst Pharm; 1998 Sep; 55(17):1755. PubMed ID: 9867409
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations for occupational exposures to HIV.
    Paul SM; Jorden V; Costa SJ; Ziskin LZ
    N J Med; 1999 Jan; 96(1):41-6. PubMed ID: 9949657
    [No Abstract]   [Full Text] [Related]  

  • 8. Failures of zidovudine postexposure prophylaxis.
    Jochimsen EM
    Am J Med; 1997 May; 102(5B):52-5; discussion 56-7. PubMed ID: 9845497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of healthcare workers.
    Cohen J; Barab J
    Am J Med; 1997 May; 102(5B):102-3. PubMed ID: 9845508
    [No Abstract]   [Full Text] [Related]  

  • 10. Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.
    Hurwitz JJ; Fine N; Rachlis AR
    Can J Ophthalmol; 1999 Jun; 34(4):195-203. PubMed ID: 10396655
    [No Abstract]   [Full Text] [Related]  

  • 11. Candidate antiretroviral agents for use in postexposure prophylaxis.
    Saag MS
    Am J Med; 1997 May; 102(5B):25-31. PubMed ID: 9845493
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.
    Lee LM; Henderson DK
    Drug Saf; 2001; 24(8):587-97. PubMed ID: 11480491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
    Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposure to HIV and post-exposure prophylaxis in healthcare workers.
    Kennedy I; Williams S
    Occup Med (Lond); 2000 Aug; 50(6):387-91. PubMed ID: 10994239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.
    Tokars JI; Marcus R; Culver DH; Schable CA; McKibben PS; Bandea CI; Bell DM
    Ann Intern Med; 1993 Jun; 118(12):913-9. PubMed ID: 8387737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arguments against the chemoprophylactic use of zidovudine following occupational exposure to the human immunodeficiency virus.
    Robinson EN
    Clin Infect Dis; 1993 Mar; 16(3):357-60. PubMed ID: 8452946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.S. Public Health Service updates guidelines for HIV prophylaxis in health care workers.
    Morey SS
    Am Fam Physician; 1998 Dec; 58(9):2165-8. PubMed ID: 9861884
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospital security: 'stay current' on HIV exposure treatment guidelines.
    Hosp Secur Saf Manage; 1997 Dec; 18(8):1-3. PubMed ID: 10176068
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-HIV chemoprophylaxis for blood-exposure accidents].
    Bouvet E; Casalino E
    Ann Med Interne (Paris); 2000 Jun; 151(4):283-90. PubMed ID: 10922956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on HIV chemoprophylaxis following exposure.
    Flaxman NA; Reed HS
    J Tenn Dent Assoc; 1997 Oct; 77(4):42-4. PubMed ID: 9520762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.